Pathway Ventures invests in early-stage startups that are driving economic mobility through innovative new models of earning, learning, and community-building. Daniel founded Pathway Bioventures in 2018 to accelerate the growth of groundbreaking early-stage life sciences companies. Pathway is a leading provider of customized private market solutions with more than $95 billion of AUM from private equity, private credit, ...
This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.